Inhibition of iNOS augments cardiovascular action of noradrenaline in streptozotocin-induced diabetes

Cardiovascular Research

Volumn 64, Issue 2, 2004, Pages 298-307

  Cheng, Xing ^a   Cheng, Xiao Shuo ^a   Kuo, Kuo Hsing ^a   Pang, Catherine C Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

iNOS; Noradrenaline; Reverse transcription polymerase chain reaction

Indexed keywords

3 NITROTYROSINE; ACETAMIDINE DERIVATIVE; ENZYME INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; N 3 AMINOMETHYLBENZYLACETAMIDINE; NORADRENALIN; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR PERFORMANCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE DP-DT; IMMUNOHISTOCHEMISTRY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES COMPARISON; STREPTOZOCIN DIABETES; VASCULAR RESISTANCE;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; AMIDINES; ANIMALS; BENZYLAMINES; BLOOD PRESSURE; DEPRESSION, CHEMICAL; DIABETES MELLITUS, EXPERIMENTAL; MALE; MYOCARDIAL CONTRACTION; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NOREPINEPHRINE; PROPRANOLOL; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TYROSINE; VASCULAR RESISTANCE;

EID: 5444220013     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.06.023     Document Type: Article

References (53)

1. B. Rodrigues, and J.H. McNeill Cardiac function in spontaneously hypertensive diabetic rats Am. J. Physiol. 251 1986 H571 H580
2. R.T. Dowell, F.L. Atkins, and S. Love Integrative nature and time course of cardiovascular alterations in the diabetic rat J. Cardiovasc. Pharmacol. 8 1986 406 413
3. D.J. Paulson, S.J. Kopp, J.P. Tow, and D.G. Peace Effects of vanadate on in vivo myocardial reactivity to norepinephrine in diabetic rats J. Pharmacol. Exp. Ther. 240 1987 529 534
4. D.J. Paulson, S.J. Kopp, J.P. Tow, J.M. Feliksik, and D.G. Peace Impaired in vivo myocardial reactivity to norepinephrine in diabetic rats Proc. Soc. Exp. Biol. Med. 183 1986 186 192
5. S.E. Litwin, T.E. Raya, P.G. Anderson, S. Daugherty, and S. Goldman Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle J. Clin. Invest. 86 1990 481 488
6. H. Okayama, M. Hamada, and K. Hiwada Contractile dysfunction in the diabetic-rat heart is an intrinsic abnormality of the cardiac myocyte Clin. Sci. (Lond.) 86 1994 257 262
7. A.L. Bardell, and K.M. MacLeod Evidence for inducible nitric-oxide synthase expression and activity in vascular smooth muscle of streptozotocin-diabetic rats J. Pharmacol. Exp. Ther. 296 2001 252 259
8. A. Makino, and K. Kamata Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1 Br. J. Pharmacol. 123 1998 1065 1072
9. X. Cheng, S.W.S. Leung, S.L. Lim, and C.C.Y. Pang Attenuated arterial and venous constriction in conscious rats with streptozotocin-induced diabetes Eur. J. Pharmacol. 458 2003 299 304
10. M.A. Hill, and R.G. Larkins Alterations in distribution of cardiac output in experimental diabetes in rats Am. J. Physiol. 257 1989 H571 H580
11. J.M. Smith, D.J. Paulson, and F.D. Romano Inhibition of nitric oxide synthase by l-NAME improves ventricular performance in streptozotocin-diabetic rats J. Mol. Cell. Cardiol. 29 1997 2393 2402
12. M. Tannous, R.A. Rabini, and A. Vignini Evidence for iNOS-dependent peroxynitrite production in diabetic platelets Diabetologia 42 1999 539 544
13. A. Ceriello, L. Quagliaro, and M. D'Amico Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat Diabetes 51 2002 1076 1082
14. P. Ferdinandy, and R. Schulz Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning Br. J. Pharmacol. 138 2003 532 543
15. E.A. Ellis, D.L. Guberski, B. Hutson, and M.B. Grant Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat Nitric Oxide 6 2002 295 304
16. X. Cheng, and C.C.Y. Pang Increased vasoconstriction to noradrenaline by 1400W, inhibitor of iNOS, in rats with STZ-induced diabetes Eur. J. Pharmacol. 484 2004 263 268
17. W.K. Alderton, C.E. Cooper, and R.G. Knowles Nitric oxide synthases: structure, function and inhibition Biochem. J. 357 2001 593 615
18. E.P. Garvey, J.A. Oplinger, and E.S. Furfine 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo J. Biol. Chem. 272 1997 4959 4963
19. N. Sambandam, M.A. Abrahani, S. Craig, O. Al-Atar, E. Jeon, and B. Rodrigues Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts Am. J. Physiol. Heart Circ. Physiol. 278 2000 H1874 H1882
20. J.H. McNeill Experimental models of diabetes 1999 C.R.C. Press L.L.C. Florida
21. C.C.Y. Pang Effect of vasopressin antagonist and saralasin on regional blood flow following hemorrhage Am. J. Physiol. 245 5 1983 H749 H755
22. X. Cheng, S.W.S. Leung, L.S. Lo, and C.C.Y. Pang Selective versus non-selective suppression of nitric oxide synthase on regional hemodynamics in rats with or without LPS-induced endotoxemia Naunyn. Schmiedebergs Arch. Pharmacol. 367 2003 372 379
23. F. Wu, G. Cepinskas, J.X. Wilson, and K. Tyml Nitric oxide attenuates but superoxide enhances iNOS expression in endotoxin- and IFNgamma-stimulated skeletal muscle endothelial cells Microcirculation 8 2001 415 425
24. M. Kawai, S.M. Bandiera, T.K. Chang, F.M. Poulet, P.M. Vancutsem, and G.D. Bellward Modulation of hepatic CYP2A1, CYP2C11, and CYP3A9 expression in adult rats by neonatal administration of tamoxifen Drug Metab. Dispos. 27 1999 1392 1398
25. M.W. Brands, S.M. Fitzgerald, W.H. Hewitt, and A.E. Hailman Decreased cardiac output at the onset of diabetes: renal mechanisms and peripheral vasoconstriction Am. J. Physiol. Endocrinol. Metab. 278 2000 E917 E924
26. Z. Yu, and J.H. McNeill Blood pressure and heart rate response to vasoactive agents in conscious diabetic rats Can. J. Physiol. Pharmacol. 70 1992 1542 1548
27. J.M. Foy, and P.D. Lucas Effect of experimental diabetes, food deprivation and genetic obesity on the sensitivity of pithed rats to autonomic agents Br. J. Pharmacol. 57 1976 229 234
28. P.D. Lucas Effects of streptozotocin-induced diabetes and noradrenaline infusion on cardiac output and its regional distribution in pithed rats Diabetologia 28 1985 108 112
29. C.V. Jackson, and G.O. Carrier Influence of short-term experimental diabetes on blood pressure and heart rate in response to norepinephrine and angiotensin II in the conscious rat J. Cardiovasc. Pharmacol. 5 1983 260 265
30. M.A. Hill, and R.G. Larkins Altered microvascular reactivity in streptozotocin-induced diabetes in rats Am. J. Physiol. 257 1989 H1438 H1445
31. F.L. Atkins, R.T. Dowell, and S. Love Beta-adrenergic receptors, adenylate cyclase activity, and cardiac dysfunction in the diabetic rat J. Cardiovasc. Pharmacol. 7 1985 66 70
32. J. Ren, and A.J. Davidoff Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes Am. J. Physiol. 272 1997 H148 H158
33. Z. Yu, G.F. Tibbits, and J.H. McNeill Cellular functions of diabetic cardiomyocytes: contractility, rapid-cooling contracture, and ryanodine binding Am. J. Physiol. 266 1994 H2082 H2089
34. 2+]i responses to isoproterenol and cAMP in isolated cardiomyocytes from experimental diabetic rats Am. J. Physiol. 266 1994 H2334 H2342
35. R.J. Young, R.M. Beams, and K. Carter Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysine Bioorg. Med. Chem. Lett. 10 2000 597 600
36. K. Stockklauser-Färber, T. Ballhausen, A. Laufer, and P. Rosen Influence of diabetes on cardiac nitric oxide synthase expression and activity Biochim. Biophys. Acta 1535 2000 10 20
37. M.H. Zou, C. Shi, and R.A. Cohen High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells Diabetes 51 2002 198 203
38. U. Chakravarthy, R.G. Hayes, A.W. Stitt, E. McAuley, and D.B. Archer Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products Diabetes 47 1998 945 952
39. M.P. Gordge How cytotoxic is nitric oxide? Exp. Nephrol. 6 1998 12 16
40. H. Ischiropoulos Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species Arch. Biochem. Biophys. 356 1998 1 11
41. J.N. Keller, and M.P. Mattson Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system Rev. Neurosci. 9 1998 105 116
42. T. Akaike, M. Suga, and H. Maeda Free radicals in viral pathogenesis: molecular mechanisms involving superoxide and NO Proc. Soc. Exp. Biol. Med. 217 1998 64 73
43. P. Ferdinandy, H. Danial, I. Ambrus, R.A. Rothery, and R. Schulz Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure Circ. Res. 87 2000 241 247
44. A. Ceriello, F. Mercuri, and L. Quagliaro Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress Diabetologia 44 2001 834 838
45. A. Ceriello, L. Quagliaro, and B. Catone Role of hyperglycemia in nitrotyrosine postprandial generation Diabetes Care 25 2002 1439 1443
46. G. Kumaramanickavel, S. Sripriya, R.N. Vellanki, N.K. Upadyay, S.S. Badrinath, and V. Rajendran Inducible nitric oxide synthase gene and diabetic retinopathy in Asian Indian patients Clin. Genet. 61 2002 344 348
47. B.J. Morris, A. Markus, C.L. Glenn, D.J. Adams, S. Colagiuri, and L. Wang Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes J. Mol. Med. 80 2002 96 104
48. A.D. Seftel, N.D. Vaziri, Z. Ni, K. Razmjouei, J. Fogarty, and N. Hampel Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS Urology. 50 1997 1016 1026
49. A. Carmo, J.G. Cunha-Vaz, A.P. Carvalho, and M.C. Lopes Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability Nitric Oxide 4 2000 590 596
50. K. Suzuki, M. Nishizawa, M. Ichikawa, K. Kumagai, M. Ryuzaki, and H. Kumagai Basal sympathetic nerve activity is enhanced with augmentation of baroreceptor reflex in Wistar fatty rats: a model of obesity-induced NIDDM J. Hypertension 17 1999 959 964
51. S.H. Carlson, J. Shelton, C.R. White, and J.M. Wyss Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats Hypertension 35 1 Pt 2 2000 403 408
52. K. Kondo, T. Matsubara, J. Nakamura, and N. Hotta Characteristic patterns of circadian variation in plasma catecholamine levels, blood pressure and heart rate variability in Type 2 diabetic patients Diabet. Med. 19 2002 359 365
53. Y. Hirooka, T. Kishi, K. Sakai, H. Shimokawa, and A. Takeshita Effect of overproduction of nitric oxide in the brain stem on the cardiovascular response in conscious rats J. Cardiovasc. Pharmacol. 41 Suppl. 1 2003 S119 S126 [Review]